Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 18, 2023

BUY
$2.83 - $4.94 $60,578 - $105,745
21,406 Added 2846.54%
22,158 $62,000
Q1 2023

Apr 13, 2023

BUY
$4.89 - $12.27 $3,677 - $9,227
752 New
752 $3,000
Q2 2022

Jul 25, 2022

SELL
$7.45 - $13.84 $180,424 - $335,177
-24,218 Reduced 89.8%
2,751 $25,000
Q1 2022

May 02, 2022

SELL
$9.94 - $12.65 $4,343 - $5,528
-437 Reduced 1.59%
26,969 $327,000
Q4 2021

Jan 28, 2022

BUY
$11.99 - $18.14 $328,597 - $497,144
27,406 New
27,406 $333,000

Others Institutions Holding CARA

About Cara Therapeutics, Inc.


  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $262M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.